Found 21 matching trials
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection PHASE2 Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor ...
Show More Status
Active Not Recruiting
Location
Thai Red Cross AIDS Research Centre
Learn More & Join Trial
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy EARLY_PHASE1 This early phase I trial tests the safety and how well N-803 works in treat...
Show More Location
Northwestern University
Learn More & Join Trial
Immunotherapy Before and After Surgery PHASE2 This Phase 2 clinical trial is testing a new immunotherapy combination (N-8...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer PHASE2 This is phase 2 single arm study evaluating the safety and preliminary effi...
Show More Location
Chan Soon-Shiong Institute for Medicine
Learn More & Join Trial
Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS) PHASE2 This Phase 2 study tests whether adding two immune therapies - nogapendekin...
Show More Location
Multiple Locations
Learn More & Join Trial
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer PHASE1 Background:
Endometrial cancer (EC) of the uterus is becoming more common ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma PHASE2 Open-Label, Phase 2 Chemotherapy-Free Study ofCD19 t-haNK and NAI in Combin...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission PHASE1 This is a phase I, randomized, open-label trial to investigate the safety o...
Show More Location
Thai Red Cross AIDS Research Centre (TRCARC)
Learn More & Join Trial
A Study to Assess Anktiva in Patients With Long Covid-19. PHASE2 This study will test the safety and tolerability of Anktiva in patients wit...
Show More Location
University of California - San Francisco
Learn More & Join Trial